Christopher B. Little spends much of his time researching Cartilage, Aggrecan, Osteoarthritis, Proteoglycan and Biochemistry. His Cartilage study integrates concerns from other disciplines, such as Extracellular matrix, Internal medicine and Endocrinology. His Aggrecan research includes themes of ADAMTS, Glycosaminoglycan, Immunology, Aggrecanase and Cell biology.
His Osteoarthritis study is concerned with the larger field of Pathology. In Pathology, Christopher B. Little works on issues like Animal model, which are connected to Disease process. In his research on the topic of Biochemistry, Extracellular, Hyaluronidase, Extracellular Matrix Degradation and Organ culture is strongly related with Synovial joint.
Christopher B. Little mainly investigates Cartilage, Osteoarthritis, Pathology, Aggrecan and Cell biology. Christopher B. Little has researched Cartilage in several fields, including Internal medicine, Matrix metalloproteinase, Arthritis and Endocrinology. His work in Osteoarthritis covers topics such as Gene expression profiling which are related to areas like microRNA.
The Pathology study combines topics in areas such as Lumican and Intervertebral disc. Christopher B. Little combines subjects such as ADAMTS, Proteoglycan, Biochemistry, Aggrecanase and Molecular biology with his study of Aggrecan. His Cell biology study combines topics in areas such as Stromal cell and Immunology.
His main research concerns Osteoarthritis, Cartilage, Pathology, Inflammation and Stem cell. His biological study spans a wide range of topics, including Synovitis, Stem-cell therapy, Anterior cruciate ligament, Internal medicine and Histopathology. In his study, Blot, Molecular biology and Regeneration is strongly linked to Matrix metalloproteinase, which falls under the umbrella field of Cartilage.
His Pathology study incorporates themes from Antibody and Serology. His Inflammation research incorporates elements of Phenotype, Implant, Drug and Arthritis. Christopher B. Little interconnects Mesenchymal stem cell, Disease and Bioinformatics in the investigation of issues within Stem cell.
His primary areas of investigation include Osteoarthritis, Cartilage, Pathology, Inflammation and Research design. His work carried out in the field of Osteoarthritis brings together such families of science as Endocrinology, Stem cell, Metalloproteinase, Regeneration and Mesenchymal stem cell. His Cartilage research integrates issues from Molecular biology, ADAMTS, Matrix metalloproteinase and Blot.
His work deals with themes such as Antibody and Serology, which intersect with Pathology. Christopher B. Little interconnects Oral administration, Diclofenac, Implant and Arthritis in the investigation of issues within Inflammation. His biological study spans a wide range of topics, including Phenotype, Disease burden and Knowledge management.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse
N. Gerwin;A. M. Bendele;S. Glasson;Cathy S Carlson.
Osteoarthritis and Cartilage (2010)
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
Heather Stanton;Fraser M. Rogerson;Charlotte J. East;Suzanne B. Golub.
Nature (2005)
Are animal models useful for studying human disc disorders/degeneration?
Mauro Alini;Stephen Eisenstein;Keita Ito;Christopher Little.
European Spine Journal (2008)
MATRIX METALLOPROTEINASE-13 DEFICIENT MICE ARE RESISTANT TO OSTEOARTHRITIC CARTILAGE EROSION BUT NOT CHONDROCYTE HYPERTROPHY OR OSTEOPHYTE DEVELOPMENT
C. B. Little;A. Barai;D. Burkhardt;S. M. Smith.
Arthritis & Rheumatism (2009)
Mechanisms involved in cartilage proteoglycan catabolism.
Bruce Caterson;Carl R. Flannery;Clare Elizabeth Hughes;Chris B. Little.
Matrix Biology (2000)
n-3 Fatty Acids Specifically Modulate Catabolic Factors Involved in Articular Cartilage Degradation *
Clare L. Curtis;Clare Elizabeth Hughes;C. R. Flannery;Chris B. Little.
Journal of Biological Chemistry (2000)
Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Chris B. Little;Carl R. Flannery;Clare E. Hughes;John S. Mort.
Biochemical Journal (1999)
Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids.
Clare L. Curtis;Sarah G. Rees;Chris B. Little;Carl R. Flannery.
Arthritis & Rheumatism (2002)
Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair
Christopher B. Little;Clare T. Meeker;Suzanne B. Golub;Kate E. Lawlor.
Journal of Clinical Investigation (2007)
Proteoglycan degradation by the ADAMTS family of proteinases.
Heather Stanton;James Melrose;Christopher B. Little;Amanda J. Fosang.
Biochimica et Biophysica Acta (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cardiff University
Cardiff University
Royal Children's Hospital
University of Melbourne
Hudson Institute of Medical Research
University of Queensland
Cardiff University
University of Oxford
Department for Environment Food and Rural Affairs
University of Sydney
United States Census Bureau
The University of Texas at Austin
The Ohio State University
University of Washington
University of Glasgow
Institute of Agrifood Research and Technology
Oregon Health & Science University
James Cook University
Wildlife Conservation Society
University of Lausanne
Queen Mary University of London
University of Campania "Luigi Vanvitelli"
Brandeis University
University of Sydney
University of St Andrews
University of Nottingham